Two lawmakers question EPA on asbestos after Reuters report

WASHINGTON (Reuters) - Two Democratic U.S. lawmakers have called on the Environmental Protection Agency to answer questions about asbestos exposure after Reuters reported that documents showed Johnson & Johnson knew for decades of the mineral’s presence in its popular baby powder.

Whether asbestos in the talc supply in Johnson & Johnson’s Baby Powder caused cancer...

Two lawmakers question EPA on asbestos after Reuters report Continue reading…

J&J loses bid to have $4.7 billion talc verdict set aside, vows to appeal

(Reuters) - Johnson & Johnson failed to persuade a Missouri trial judge to set aside a July verdict awarding a record $4.69 billion to 22 women who blamed their ovarian cancer on asbestos in the company’s Baby Powder and other talc products.

The healthcare company faces thousands of lawsuits over the safety of talc in...

J&J loses bid to have $4.7 billion talc verdict set aside, vows to appeal Continue reading…

Allergan stops sale of textured breast implants in Europe, shares sink

NEW YORK (Reuters) - Drugmaker Allergan Plc said on Wednesday it would take its textured breast implants off the market in Europe, a day after a French regulatory body ordered a recall of the implants, which have been linked to a rare form of cancer.

Allergan defended the safety of its breast implants, but its...

Allergan stops sale of textured breast implants in Europe, shares sink Continue reading…

Breakingviews – J&J’s talc crisis will linger for years

NEW YORK (Reuters Breakingviews) - Johnson & Johnson’s talc crisis will linger for years. Investors erased $40 billion of its market value on Friday, after Reuters revealed the U.S. healthcare giant knew for decades its baby powder was sometimes tainted by asbestos. The company says the story is an “absurd conspiracy theory” as “every...

Breakingviews – J&J’s talc crisis will linger for years Continue reading…

Kotex Recalls Some Tampons After Reports Of Unraveling Inside Body

Kimberly-Clark has issued a voluntary recall of some U by Kotex tampons, after a "quality-related defect" caused the tampons to come apart inside of consumers' bodies, leaving pieces behind after the tampon was removed.

The problematic tampons have pushed users to "seek medical attention to remove tampon pieces left in the body," the personal care...

Kotex Recalls Some Tampons After Reports Of Unraveling Inside Body Continue reading…

J&J Starts Settling Suits Over Pinnacle Hip Defect Claims

Johnson & Johnson has begun settling consumers’ claims that it sold artificial hips knowing they were defective, marking the first settlements in the seven-year-old litigation.

A federal judge in Texas overseeing the cases said about 3,300 of 10,000 “have settled or are in the process of settling,’’ according to a Dec. 9 court filing. Terms...

J&J Starts Settling Suits Over Pinnacle Hip Defect Claims Continue reading…

Infant ibuprofen recall: Walmart, CVS Pharmacy and Family Dollar lots impacted

Infant ibuprofen destined to be sold at several national retailers might contain a higher concentration of ibuprofen, leading to potential risks in infants, according to a Wednesday voluntary recall notice.

New Jersey-based Tris Pharma, Inc. said lots sold under Walmart, CVS Pharmacy and Family Dollar brands are impacted by the recall. The products were labeled...

Infant ibuprofen recall: Walmart, CVS Pharmacy and Family Dollar lots impacted Continue reading…

FDA recalls blood pressure medication for cancer-causing risk

The Food and Drug Administration has issued a recall for the blood pressure medication Valsartan because it has the possibility to cause cancer.

However, the FDA advises people to continue use of the medication until they can talk with their doctor, saying the risk of immediately stopping the pills is greater than the possibility of...

FDA recalls blood pressure medication for cancer-causing risk Continue reading…

Breast Implant Injuries Kept Hidden As New Health Threats Surface

More than 10 million women worldwide have received breast implants over the last decade, a remarkable comeback for a medical product that had suffered a crippling safety scandal and a lengthy ban in the United States.

The U.S. Food and Drug Administration’s decision to restore silicone implants to the market in 2006 followed an earlier...

Breast Implant Injuries Kept Hidden As New Health Threats Surface Continue reading…

Doctors: Blood pressure drug substitutes are available for patients affected by recalls

Doctors say patients with high blood pressure should pay attention to and be ready to act on the trickle of drug recalls involving a commonly prescribed type of blood pressure medication – but warned against dropping a medicine without consulting a physician or pharmacist.

The Food and Drug Administration announced the recall of several versions...

Doctors: Blood pressure drug substitutes are available for patients affected by recalls Continue reading…